Tuesday, 12 November 2013

The not-green ocean

That the ocean is blue and not green is evident, yet the reason for this is not as silly as one would think.

In fact planktonic algae are not as abundant as they could could be, if it were not for phosphorous and iron limitation. If life could survive off air and the minerals in sea water alone, the ocean would be as green as a rainforest —or whatever colour the photosynthetic pigment of this hypothetical life were to be. Light gives power, carbon can be fixed from carbon dioxide and amino groups can be obtained from nitrogen gas —with some trouble—, while phosphorus tends to be insoluble so comes from rocks: there are no rocks on the open ocean surface.

There is a counter-intuitive phenomenon called eutrophication where, when nitrogen and/or phosphorus get dumped into a river or lake, an algal bloom occurs, which blocks the light to the bottom of the watermass and the decomposing dead alga result in oxygen deprivation. This just show how some elements are the rate limiting step for a green watermass. Adding nutrients before the tipping point, results in a more lush ecosystem. There are a lot of pipe-dreamy talks of phosphorous and iron fertilisation of the oceans to combat CO2 levels: forest occupy only 7% of the planets surface, whereas oceans occupy 71%, so there is a lot of carbon fixing that could be going on that isn't. What interests me, however, is how could Nature overcome the issue.

Ammonia causes eutrophication because it is limiting as nitrogen fixation is neither simple or cheap, but it can and is made, albeit slowly. The major issue is the fact that splitting N2 costs 4 pairs of high energy electrons and O2 quenches the reaction in nearly all nitrogenases.

Whereas strategies to avoid oxygen sensitivity in nitrogenases can (and maybe has) evolve, phosphate and iron limitation is an insurmountable issue.

Iron is a big problem, for starters no iron means no heam and no iron-sulfur clusters, which catalyse several complex reactions, including that of nitrogenase. The problem is actually greater as except for alkali metals, there are a few parts per billion or less of most metals. The reactions vary, but not many of them could be substituted by hypothetical delocalised pi orbitals, other larger elements and similar. So the metal dependence is unavoidable.
Also, it is a fairly safe guess that life will not evolve to be phosphorous-less any time soon: the genome (DNA) needs it, the transcriptome (RNA) needs it and the cellular energetic currency (ATP) needes it. The best evolution can do is to streamline the genome to the bare minimum. There is a lot of talk about nucleic acid analogous with carbon-based backbones, most which do not form helices but tangled messes —hey, they are still amazing. So engineering such a phosphorous-free organism is out of the realm of what is current feasible in synthetic biology and more in the realm of science fiction. Plus, if the oceans were dominated by a (planet-saving) spooky GM organism, prince Charles would never shut up.
I am not aware of any other oxygenated multivalent ions that would fit the bill or that have even been tested, for example nitrate-backboned DNA would be very explosive, whereas sulfate-backboned DNA would be neutrally charged, but the question if an element other than phosphorous would work is pretty cool and is comparable to the debate of the fictional arsenic bacterium.
If there were some non-phosphorous system that did form helices… the genome would still be different, requiring new polymerases and XNA-binding proteins. The transcriptome would be different as RNA would not fold making riboswitches, tRNA and other quirky RNA structures unusable. The transcription machinery would have to be fully proteinaceous. The energy storing bond would have to be something different (acetyl-CoA or something radically new)... but rather cool.

Thursday, 5 September 2013

Conferences (NZSBMB)

Report for the NZSBMB

Conferences are about learning. And from them I have learnt a lot, not only in terms of scientific knowledge, but also in terms of common sense.
I went to two conferences in July, namely SMBE 2012 (Society for Molecular Biology and Evolution) in rainy Dublin —Ireland was rightfully called Hibernia, the land of winter, by the Romans— and the Gordon Biocatalysis 2012 conference in sweltering Rhode Island.
The first thing I learnt was that three successive red-eye flights are a bad idea regardless of cheapness and of how well-travelled one is as no amount of travelling can make one prepared for it. Another thing I learnt was that when the airhostess insists a poster-tube be given to her for stowage one should behave like a tigress protecting her cubs, lest one want it inexplicably sent to Denver…
The lab I work in studies enzyme evolution via promiscuity, which means that we scare evolutionary biologists by talking about kcat and KM values and enzymologists by talking about selection pressures. Therefore, I went to two conferences, one for each side. The work I presented as a poster was the change of various enzymatic activities (main and promiscuous) of an enzyme across different lineages.
The SMBE is a big conference, which is not necessarily a good thing. There were six parallel sessions, which nominally means one could go to relevant ones and avoid the irrelevant ones and within the first day I mastered the art of flitting from one session to the other. However, I soon found out that some sessions I was very keen on were full to (EU fire-code) capacity. A further side effect of parallel session is that often one has to make a tough choice between two interesting talks, whereas at other times one has to choose from a series of utterly uninspiring talks.
In addition to talks, there were the poster sessions, where I presented my newly reprinted poster. Many complicated factors are at play in the (unappreciated) art of poster placement in a hall. The main factor that determines whether a passer-by stops to read a poster is not due to the content —although a QR code can help—, but due to the presence of other readers (nucleators). Therefore, due to the queues, being close to the bar is probably one of the best places to attain this phenomenon. And next to the bar was exactly were my poster was.
My second conference, the Gordon Biocatalysis conference, was diametrically opposite: it was small, which meant it was a good environment to easily interact with other participants, both students and faculty. The talks were longer (i.e. not crammed) and all were fascinating. I left the conference having met many really smart and nice people, having learnt a lot about the frontiers of research and having been awed by what the future holds in store.
I did however learn another piece of common sense, namely to not make promises that can’t be kept: I promised Wayne, my supervisor, I would not do anything embarrassing, yet I did so twice. In a first instance, there was a discussion of Star Trek that degenerated into a biggest trekkie competition, which I unfortunately “won” by having been wearing star trek themed socks. Then during a free afternoon, I let out a bellowing scream when a volleyball flew towards me —referred to by others as my Klingon battlecry. Not my finest hour…

Thursday, 1 August 2013

Phylogenetic clunkiness

Writing a bacterial phylogenetics paper is probably the most agonizing type of paper to write due to the clunkiness of the language. But it's not the jargon that make life hell, it's the missing jargon that make it hard. The quantity of jargon actually make life a bit easier, but the lack of some blatantly useful words makes it painfully clunky and stuffy.
Reading a phylogenetics paper is generally visually painful due to the frequent usage of italics and "quote" marks. A phenomenon that I once read described aptly as a "typographic circus" by someone on a Wikipedia talk page. The italics are for taxa described validly according to the bacteriological code, whereas quotes are reserved for candidate taxa which have not been validated yet —the bugs exist, but nobody has done the paperwork. Nevertheless, the aesthetic problem is trivial compared to the lexal ones…
One such problem is the lack of trivial names (common names).
Only a few groups of  bacteria have trivial names and for some reason in microbiology, unlike botany, scientific names are rarely "trivialised", a process of making an English word for a member of a taxa, for example, a crustacean is a member of the family Crustacea and a bromeliad is a member of the genus Bromelia.
The most notable exceptions are a proteobacterium (a member of the phylum Protobacteria), an enterobacterium (a member of the family Enterobacteriales) and a pseudomonad (a member of the genus Pseudomonas). This is a shame as it circumvents the repetitive clunkiness and stuffiness. Taxonomic names, after all, are labels for the group, which can adopt a metaphorical usage to denote one of its members, primarily due to the quirkiness of the Latin name: for example, a group of sheep is a flock, but calling a single sheep a flock would sound awkward, whereas calling a sheep an Ovis sounds less weird, just technical. However, the phrase "a member of the" becomes really trite really quickly, one alternative is to use the word sp. (species), but it is still a bit weird: is the supposed to be the indefinite article "an" before Ovis sp.? A further perk is that a trivial name often allows adjectives to be formed, which is much nicer to read than a noun used adjectivally or "of the".
This last note is related to another problem with the Latin grammar of the nomenclature: all higher ranked names are plurals in Latin whereas there is only one of them (there are several members). In Latin (and other romance languages) collective nouns are plurals, whereas in English they are generally singulars (grammatical concord), but can be treated as plurals in informal speech (notional concord), e.g. the Alps is a mountain range (grammatical concord), the band are playing (notional concord). It does seem like a minor nuisance, but it gets really knotty when describing relationships and last common ancestors… on the plus side though the pride in the "look at my fancy Latin" is pretty nice.

Monday, 29 July 2013

Metabolic engineering Breaking Bad

Disclaimer: Obviously, this is a speculative what-if out of intellectual curiosity and by no means condones narcotics and their creation.
Update: This post was written when the hit show Breaking Bad was still on TV and the chemistry on the show were commonly discussed and joked about, so please keep that in mind.
The logo of Breaking Bad had it been bio.
Half the issues in Breaking Bad could have been solved if they had been using biocatalysis and metabolic engineering. The catch is that nobody has made a production strain and it is not a simple task.

Biocatalysis: greener and safer

Some time soon, biocatalysis and metabolic engineering will replace many heterocatalytic processes as it is more efficient, cheaper, safer and greener.
Worldwide, there is a big problem of exploding methamphetamine labs. This problem could be fixed by switching from toxic and dangerous heterocatalysis processes to green and safe biocatalysis ones.

Requirements

So if Walt and Jessie wanted to win the green chemistry award, what would they need to do?
Their major problem is the starting material and the production steps. So the whole lot. Therefore, they need to do metabolic engineering.
The major issue is that methamphetamine is not a natural compound, so extensive engineering would be needed to produce the final steps. However, once they laboriously made a production strain, they would need to set up a large-scale bioreaction, i.e. a brewing tank, extract the product by phase-separation, remove the solvent and purify by crystallisation as they normally do. Then the only worry then is that they may be as contaminant-prone as Hank is at brewing.

Starting point

Methamphetamine is a compound that looks like phenyalanine, but on the chiral α-carbon there is methyl group instead of a carboxyl one and the amine group is methylated.
The natural molecules most similar to methaphetamines are pseudoephedrine and ephedrine. These two diastereomers differ from the former in having a hydroxyl group (in different chiral orientations) on the carbon adjacent to the benzene ring. The biosynthetic pathway is known (PMID 22502775), but requires eleven steps, which have not been assembled exogenously in an orderly way.
Additionally, to convert ephedrine to methamphetamine new enzymes need to be engineered for the hydroxyl reduction, which is problematic. Consequently, ephedrine biosynthesis might not be the best route and instead something more radical may be in order.

Ephedrine biosynthesis

Ephedrine gets its name from the genus Ephedra, whose members produce it. Unfortunately the selective pressures for plant secondary metabolism are rather unusual (cool) and as a result the metabolic routes get a tad tortuous.
If one were to forget how plants like to do things, one would guess a simple pathway with a similar logic to threonine biosynthesis be present. Namely, the carboxyl is twice reduced and the remaining hydroxyl is isomerised to the right place.

The final step (not pictured), the N-methylation, would be simply accomplished by a SAM-dependent methyltransferase and is the only part that is correct.
In the isomeration step, one might anticipate that an enamine-ketimine tautomerism followed by an attack by water might occur ruining the effort. However, the isomerisation of homserine to threonine is done via a PLP enzyme which holds the amine, so this isn't the problem.

The problem is plants like to make second metabolism in an OCD way, starting from specific compounds (e.g. geranyl-PP, farnesyl-PP, cinnamoyl-CoA, coumaroyl-CoA, malonyl-CoA and acetyl-CoA), preferably using decarboxylative condensation.
The ephedrine pathway is no exception and shares the beginning of the pathway with many other compounds Phenylanine > cinnamic acid > cinnaomyl-CoA>>benzoyl-CoA. Then the unique part is that the benzoyl-CoA is condensed with pyruvate, reduced and transaminated.
In reality, whereas the full pathway is known, the genes themselves are not, simply because nobody has sequenced E. sinica. Although a group in 2009 has gone to the effort of making yeast take up the DNA of E. glauca via ion implantation —no kidding around there!— and make ephedrine, but they did not sequence a few hybrids or similar, but instead did a lot of tedious work with primers (PMID: 19280123). Consequently, their experiment would need to be repeated, but with sequencing.
Once the various genes are cloned into E. coli, preferable into a strain that overproduces phenylalanine (eg. from PMID: 17880710), the pathway would be optimised, giving an ephedrine-producing strain.

The last step

The last step is the trickiest.
After those few years of work are done, the hydroxyl needs to be removed reductively.
Hydroxyl/water is a terrible leaving group when not activated (i.e. phosphorylated) or using a resonance trick. Biochemically, hydroxyl groups are normally removed in two steps, the hydroxyl group is removed without adding an electron pair to the molecule by a hydroxylase which leaverages a nearby tautomerise-able group, therefore leaving a double-bonded carbon, which is then reduced by a reductase.  In some rare cases, the hydroxyl is reduced away directly. The most famous example is ribonucleotide reductase. The mechanism is rather satanic —a radical-assisted dehydration coupled to oxidation of the C3′ alcohol to a ketone, which starts with a HAT from the adjacent carbon (C3′), resulting in a carbonyl radical that provides a powerful electronic driving force for eliminating water at C2′ (pinacol rearrange with radical vibes), and ends in a proton-coupled electron transfer.
The dehydration route is a problematic option however. A modified 3-hydroxyacyl-ACP dehydrase and the enoyl-ACP reductase from the fatty acid biosynthetic pathway seem like good candidates. However, the dehydrated enolamine would spontaneously tautomerise and hydrolyse as mentioned above.
This might not be that catastrophic as the product would be phenylpropanone, which being similar to phenylpropane-dione, the product of the pyruvate-benzoyl-CoA condensation. It might be promiscuously transaminated again by the cathionine transaminase or by phenylamine transaminase.
Nevertheless it is an odd way of doing things.
The N-methylation must be done last as the product is slippery being so hydrophobic. Normally, biochemistry likes to put a handle to hold stuff like that, such as phosphates, CoA and glycosides. In this case, a N-glycosilation would be a good option. The best bet, however, would be to move the N-methylation step after the hydroxyl reduction, the methyltransferase cannot discern between the precursor for ephedrine or pseudoephedrine, so it is probably fairly accommodating towards amphetamine.

Crazy way

The carboxyl group needs to be replaced with a methyl group. This is not an option from a biochemists' perspective as C-C bonds cannot be made that easily, unless by condensation or transmethylation on aromatic structures. In a typical methyltransferase the methyl donor is SAM, while the acceptor is a nucleophile (Lewis base), such as an amine or a hydroxyl that has been deprotonated by a catalytic acid. From a technical point of view as far as I can tell there should not be anything forbidding a PLP and SAM dependent decarboxylative C-methylation. After a decarboxylation the negative charge is partially absorbed by the PLP (electron sink), leaving an nucleophilic secondary aldimine. The enzymatic reside that favoured the departure of the carboxyl group (say, catalytic lysine) might compete with the SAM though.

In the literature there is no sign of such a reaction: there is a decarboxylative O-methyltransferase (PMID: 22247507) and the various cases of SAM and PLP dependent enzymes, e.g. aminomutases, rely on SAM as a radical donor. There are some enzymes that point towards the possibility of such a C-methyltransferase, such as on an enol-ketone tautomerism (PMID: 5490210 and PMID: 17784761). Nevertheless, such an enzyme, if possible, would require a lot of work and luck to pull off. So the safer option might sound a lot longer, but has a higher chance of working...

Selection

A side question is how to select for better variants. To evolve a strain to make methamphetamine an way to select for one is obviously needed.
The traditional way would be to assay for those compounds by HPLC, but this would mean that the variants would be screened laboriously (especially in light of the optimisation required).
An option for a high-throughput approach is to make a transcription factor that responds only to the substance needed, so that it activates a fluorescent reporter which can be selected by a FACS (eg. PMID: 22276138). Unfortunately, the targets of amphetamines and those of catecholamines are membrane receptors. So the phenylalanine binding TF, tyrR-econded, would be a good candidate for engineering.

Toxicity

The oral murine LD50 of methamphetamine is slightly higher than capsaicin (55 vs. 46 mg/kg), so it is probably non-toxic to bacteria and due to its hydrophobicity it can be phase-separated easily from the aqueous environment. So a least one bit would be straight-forward.

Conclusion

Given the recombination and sequencing for gene identification, the many rounds of engineering and so forth, it would be five years if they are lucky. So metabolic engineering breaking bad would not start even at its fifth season...
And it would be expensive to do and there is no guarantee that their strain would remain safe — copying Walter's formula was an issue, here it would require only a stolen tube.
In brief, it would actually be a real pain to do and take years to cobble together, so unfortunately, metabolic engineering cannot make Walter and Jessie more green and free of precursor woes...